Search results for "Body fluid"

showing 10 items of 145 documents

Physiologically based metformin pharmacokinetics model of mice and scale-up to humans for the estimation of concentrations in various tissues

2020

Metformin is the primary drug for type 2 diabetes treatment and a promising candidate for other disease treatment. It has significant deviations between individuals in therapy efficiency and pharmacokinetics, leading to the administration of an unnecessary overdose or an insufficient dose. There is a lack of data regarding the concentration-time profiles in various human tissues that limits the understanding of pharmacokinetics and hinders the development of precision therapies for individual patients. The physiologically based pharmacokinetic (PBPK) model developed in this study is based on humans’ known physiological parameters (blood flow, tissue volume, and others). The missing tissue-s…

MalePhysiologyAdipose tissueType 2 diabetesPharmacology030226 pharmacology & pharmacyMice0302 clinical medicineAnimal CellsRed Blood CellsMedicine and Health SciencesTissue Distribution0303 health sciencesMultidisciplinarySimulation and ModelingQRMetforminBody Fluids3. Good healthMetforminBloodmedicine.anatomical_structureSmall IntestineMedicineAnatomyCellular TypesResearch Articlemedicine.drugPhysiologically based pharmacokinetic modellingScienceExcretionCmaxResearch and Analysis MethodsModels BiologicalBlood Plasma03 medical and health sciencesPharmacokineticsmedicineAnimalsHumansHypoglycemic AgentsComputer SimulationPharmacokinetics030304 developmental biologyPharmacologyBlood CellsDose-Response Relationship Drugbusiness.industryBiology and Life SciencesKidneysRenal SystemCell BiologyBlood flowmedicine.diseaseSmall intestineGastrointestinal TractDiabetes Mellitus Type 2Physiological ProcessesbusinessDigestive SystemPLOS ONE
researchProduct

Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?

2021

BackgroundCirculating Neprilysin (sNEP) has emerged as a potential prognostic biomarker in heart failure (HF). In PARAGON-HF benefit of sacubitril/valsartan was only observed in patients with left ventricular ejection fraction (LVEF) ≤57%. We aimed to assess the prognostic value of sNEP in outpatients with HF and LVEF >57%, in comparison with patients with LVEF ≤57%.MethodsConsecutive HF outpatients were included from May-2006 to February-2016. The primary endpoint was the composite of all-cause death or HF hospitalization and the main secondary endpoint was the composite of cardiovascular death or HF hospitalization. For the later competing risk methods were used.ResultssNEP was measure…

MalePhysiologyCancer TreatmentCardiovascular MedicineBiochemistrySacubitrilMedical ConditionsClinical endpointMedicine and Health SciencesMultidisciplinaryEjection fractionPharmaceuticsAminobutyratesHazard ratioQRMiddle AgedPrognosisBody FluidsCardiovascular TherapyBloodValsartanOncologyCardiovascular DiseasesCardiologycardiovascular systemMedicineValsartanFemaleNeprilysinAnatomymedicine.drugcirculatory and respiratory physiologyResearch Articlemedicine.medical_specialtyScienceCardiologyDrug TherapyInternal medicinemedicineHumanscardiovascular diseasesAgedProportional Hazards ModelsHeart FailureProportional hazards modelbusiness.industryBiphenyl CompoundsBiology and Life SciencesStroke VolumeCardiovascular Disease Riskmedicine.diseaseHeart failurebusinessSacubitril ValsartanBiomarkersReceptor Antagonist TherapyEjection FractionPloS one
researchProduct

Delivery of epirubicin via slow infusion as a strategy to mitigate chemotherapy-induced cardiotoxicity

2017

Background Continuous infusion of doxorubicin has been a strategy to reduce cardiotoxicity. Epirubicin is another anthracycline in common clinical use. However, evidence is lacking regarding whether this strategy can reduce cardiotoxicity of epirubicin without compromising antineoplastic efficacy. Design and methods Healthy rats were randomized into groups: epirubicin (8 mg/kg) delivered intraperitoneally via micro osmotic pumps (MOP), epirubicin (8 mg/kg) by intraperitoneal (IP) bolus injection, and placebo control. Blood samples were collected for analyzing biomarkers of myocardial injury and pharmacokinetics. At chosen times, sub-groups of animals were sacrificed for histopathology. A mo…

MalePhysiologyCancer Treatmentlcsh:Medicine030204 cardiovascular system & hematologyPharmacologyBiochemistryRats Sprague-DawleyMice0302 clinical medicineBolus (medicine)Intraperitoneal InjectionsBreast TumorsMedicine and Health Scienceslcsh:Scienceskin and connective tissue diseasesInfusions IntravenousRoutes of AdministrationMultidisciplinaryAntibiotics AntineoplasticArea under the curveHeartAnimal ModelsBody FluidsBloodExperimental Organism SystemsOncology030220 oncology & carcinogenesisAnatomyEpirubicinmedicine.drugResearch ArticleAnthracyclineMouse ModelsResearch and Analysis MethodsBlood Plasma03 medical and health sciencesModel OrganismsPharmacokineticsIn vivoCell Line TumorBreast CancermedicineAnimalsDoxorubicinPharmacokineticsAnimal Models of DiseaseEpirubicinPharmacologyCardiotoxicitybusiness.industrylcsh:RCancers and NeoplasmsBiology and Life SciencesRatsAnimal Studieslcsh:QbusinessBiomarkersPLoS ONE
researchProduct

Prolonged Cerebral Circulation Time Is the Best Parameter for Predicting Vasospasm during Initial CT Perfusion in Subarachnoid Hemorrhagic Patients

2016

Purpose We sought to imitate angiographic cerebral circulation time (CCT) and create a similar index from baseline CT perfusion (CTP) to better predict vasospasm in patients with subarachnoid hemorrhage (SAH). Methods Forty-one SAH patients with available DSA and CTP were retrospectively included. The vasospasm group was comprised of patients with deterioration in conscious functioning and newly developed luminal narrowing; remaining cases were classified as the control group. The angiography CCT (XA-CCT) was defined as the difference in TTP (time to peak) between the selected arterial ROIs and the superior sagittal sinus (SSS). Four arterial ROIs were selected to generate four correspondin…

MalePhysiologyCerebral arterieslcsh:MedicinePerfusion scanningCardiovascular MedicineDiagnostic Radiology030218 nuclear medicine & medical imagingCerebral circulation0302 clinical medicineBlood FlowMedicine and Health SciencesVasospasm IntracranialCardiovascular Imaginglcsh:ScienceRoutes of AdministrationCerebral IschemiaMultidisciplinarymedicine.diagnostic_testPharmaceuticsRadiology and ImagingAngiographyVasospasmArteriesHematologyMiddle AgedBody FluidsBloodNeurologyCerebrovascular CirculationCardiologyCalcium Antagonist TherapyFemaleRadiologyAnatomyResearch ArticleSuperior sagittal sinusmedicine.medical_specialtySubarachnoid hemorrhageImaging TechniquesPerfusion ImagingResearch and Analysis Methods03 medical and health sciencesDrug TherapyDiagnostic MedicineIntravenous InjectionsInternal medicinemedicineHumansPharmacologybusiness.industrylcsh:RHemodynamicsBiology and Life SciencesAngiography Digital SubtractionCerebral ArteriesSubarachnoid Hemorrhagemedicine.diseasenervous system diseasesHealth CareSSS*AngiographyCardiovascular AnatomyBlood Vesselslcsh:QTomography X-Ray ComputedbusinessReceptor Antagonist Therapy030217 neurology & neurosurgeryPLOS ONE
researchProduct

Aquatic cycling-What do we know? A scoping review on head-out aquatic cycling

2017

Over the past few years, aquatic cycling has become a trending fitness activity. However, the literature has not been reviewed exhaustively. Therefore, using scoping review methodology, the aim of this review was to explore the current state of the literature concerning aquatic cycling. This study specifically focused on study designs, populations and outcomes. A comprehensive search of seven databases (PubMed, MEDLINE, Cinahl, Embase, PEDro, Web of Science, WorldCat) was conducted up to 30th September 2016. GoogleScholar, World Cat, ResearchGate, specific aquatic therapy websites and aquatic therapy journals were searched to identify additional literature. Full-text publications in English…

MalePhysiologyMaternal HealthPsychological interventionlcsh:MedicineBlood PressureVascular MedicineDatabase and Informatics Methods0302 clinical medicinePregnancyHeart RateMedicine and Health SciencesMedicinePublic and Occupational HealthDatabase Searchinglcsh:ScienceMusculoskeletal SystemMultidisciplinaryTemperatureObstetrics and GynecologyResearch AssessmentSports ScienceExercise TherapyBody Fluids3. Good healthBloodSystematic reviewMeta-analysisLegsFemaleAnatomyAEROBIC EXERCISECyclingWATER IMMERSIONPREGNANT-WOMENSportsResearch ArticleSystematic ReviewsLEG EXERCISEPOWERCardiologyMEDLINECINAHLResearch and Analysis Methods03 medical and health sciencesCOLD-WATEREnvironmental healthHumansAquatic therapyCENTRAL BLOOD-VOLUMESports and Exercise MedicinePlasma VolumeTHERMAL RESPONSESExercisebusiness.industryClinical study designLimbs (Anatomy)lcsh:RWaterBiology and Life SciencesPhysical Activity030229 sport sciencesRATE-VARIABILITYPHYSIOLOGICAL-RESPONSESPhysical FitnessWomen's Healthlcsh:Qbusiness030217 neurology & neurosurgeryPLOS ONE
researchProduct

An investigation of plasma interleukin-6 in sport-related concussion

2020

Background Increasing evidence suggests inflammation is an important component of concussion pathophysiology. However, its etiology, restitution, and potential clinical repercussions remain unknown. The purpose of the current study was to compare the blood concentrations of interleukin (IL) -6, a prominent inflammatory cytokine, between healthy athletes and athletes with a sport-related concussion (SRC), while addressing the potential confounds of sex, recent physical activity, and the interacting effect of concussion history. Method A prospective, observational cohort study was conducted on athletes at a single academic institute participating across 13 interuniversity sports. Follow-up of…

MalePhysiologySocial SciencesPathology and Laboratory Medicine0302 clinical medicineImmune PhysiologyConcussionMedicine and Health SciencesPsychologyPublic and Occupational HealthProspective StudiesYoung adultProspective cohort studyImmune ResponseInnate Immune System0303 health sciencesMultidisciplinarybiologyQRSports ScienceBody FluidsBloodAthletic InjuriesRegression AnalysisCytokinesMedicineFemaleAnatomyResearch ArticleSportsCohort studymedicine.medical_specialtyScienceImmunologyBlood PlasmaYoung Adult03 medical and health sciencesSigns and SymptomsDiagnostic MedicineInternal medicinemedicineHumansSports and Exercise MedicineInterleukin 6Brain Concussion030304 developmental biologyInflammationBehaviorInterleukin-6Athletesbusiness.industryCase-control studyBiology and Life SciencesPhysical ActivityMolecular Developmentmedicine.diseasebiology.organism_classificationCase-Control StudiesImmune SystemEtiologybiology.proteinRecreationPhysiological ProcessesSleepbusiness030217 neurology & neurosurgeryDevelopmental BiologyPLOS ONE
researchProduct

Role of HDL function and LDL atherogenicity on cardiovascular risk: a comprehensive examination

2019

[Background] High-density lipoprotein (HDL) functionality and low-density lipoprotein (LDL) atherogenic traits can describe the role of both particles on cardiovascular diseases more accurately than HDL- or LDL-cholesterol levels. However, it is unclear how these lipoprotein properties are particularly affected by different cardiovascular risk factors.

MalePhysiologyhumanosLipoproteïnesBlood PressureCardiovascular Medicine030204 cardiovascular system & hematologyOxidacióBiochemistryVascular Medicinelipoproteínas616.1 - Patologia del sistema circulatori dels vasos sanguinis. Trastorns cardiovasculars:Ciencias de la Salud::Cardiología [Materias Investigacion]Endocrinology0302 clinical medicineRisk FactorsSex factorsSistema cardiovascular--MalaltiesMedicine and Health SciencesMedicine030212 general & internal medicinemediana edadancianoMultidisciplinaryQChemical ReactionsAge FactorsRMiddle AgedadultoLipidsBody FluidsLipoproteins LDLLipoproteïnes de densitat baixaChemistryBloodCholesterolCardiovascular DiseasesPhysical SciencesHypertensiondiabetes mellitusMedicineFemalelipids (amino acids peptides and proteins)AnatomyLipoproteins HDLColesterolResearch ArticleAdultEndocrine DisordersScienceLipoproteinsdislipidemiasenfermedades cardiovascularesBlood Plasma03 medical and health sciencesSex FactorsOxidationHumansfactores de riesgoAgedDyslipidemiasbusiness.industryCholesterol HDLBiology and Life SciencesProteinsCholesterol LDLAtherosclerosisSistema cardiovascular -- Malalties -- Factors de riscCross-Sectional StudiesLipoproteïnes de densitat altaDyslipidemiaDiabetes Mellitus Type 2Metabolic DisordersaterosclerosisbusinessHumanitiesestudios transversales
researchProduct

Circulating, cell-free DNA as a marker for exercise load in intermittent sports

2017

Background Attempts to establish a biomarker reflecting individual player load in intermittent sports such as football have failed so far. Increases in circulating DNA (cfDNA) have been demonstrated in various endurance sports settings. While it has been proposed that cfDNA could be a suitable marker for player load in intermittent sports, the effects on cfDNA of repeated sprinting as an essential feature in intermittent sports are unknown. For the first time, we assessed both alterations of cfDNA due to repeated maximal sprints and due to a professional football game. Methods Nine participants were subjected to a standardised sprint training session with cross-over design of five maximal s…

MalePhysiologylcsh:MedicineBiochemistryBlood Plasma796 Athletic and outdoor sports and gamesRunningMedicine and Health SciencesHumansPublic and Occupational HealthSports and Exercise Medicinelcsh:ScienceExerciseBehavior796 SportBiological Locomotionlcsh:RBiology and Life SciencesPhysical ActivitySports ScienceBody FluidsCapillariesBloodPhysical FitnessCardiovascular AnatomyRecreationBlood VesselsFemalelcsh:QAnatomyGamesCell-Free Nucleic Acidshuman activitiesBiomarkersSportsResearch Article
researchProduct

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outs…

2021

Background ADVanced Organ Support (ADVOS) is a novel type of extracorporeal albumin dialysis and holds promise to sustain liver function and recovery of patients with acute-on-chronic liver failure (ACLF). Previously, ADVOS was tested as continuous treatment for intensive care patients with liver failure. Data related to the applicability and safety as discontinuous treatment outside of ICU is not available. Aim Evaluation of ADVOS as discontinuous treatment for patients with ACLF outside intensive care unit and comparison with a matched historic cohort. Methods and results In this retrospective study, 26 patients with ACLF and the indication for renal replacement therapy related to HRS-AK…

MalePhysiologymedicine.medical_treatmentLiver transplantationToxicologyPathology and Laboratory MedicineSeverity of Illness IndexBiochemistrylaw.inventionBlood Urea Nitrogen0302 clinical medicinelawLiver Cirrhosis AlcoholicMedicine and Health SciencesMedicineBileMultidisciplinaryLiver DiseasesQRMiddle AgedIntensive care unitBody FluidsRenal Replacement TherapyLiverCirrhosisNephrologyCreatinineMedicine030211 gastroenterology & hepatologyFemaleHemodialysisAnatomyDetoxificationResearch Articlemedicine.medical_specialtyCritical CareScienceSurgical and Invasive Medical ProceduresGastroenterology and Hepatology03 medical and health sciencesDigestive System ProceduresRenal DialysisIntensive careInternal medicineAlbuminsMedical DialysisHumansRenal replacement therapyDialysisRetrospective StudiesTransplantationbusiness.industryAcute-On-Chronic Liver FailureBiology and Life SciencesProteins030208 emergency & critical care medicineRetrospective cohort studyBilirubinOrgan TransplantationSurvival AnalysisLiver TransplantationPatient ComplianceLiver functionbusinessBiomarkersPLoS ONE
researchProduct

Management of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation (ECMO): An observational cohort study.

2017

Background Intracranial hemorrhage (ICH) is a common complication in adults treated with extracorporeal membrane oxygenation (ECMO). The aim of this study was to identify predictors of outcome and investigate intervention strategies following ICH development in ECMO-treated adult patients. Methods We conducted a retrospective review of adult patients (≥18 years) who developed an ICH during ECMO treatment at the Karolinska University Hospital (Stockholm, Sweden) between September 2005 and May 2017. Outcome was assessed by 30-day mortality and Glasgow Outcome Scale (GOS) after 6 months. The statistical analysis was supplemented by a case series of patients who were surgically treated for an I…

MalePhysiologymedicine.medical_treatmentlcsh:MedicinePathology and Laboratory MedicineVascular MedicineDiagnostic RadiologyCohort Studies0302 clinical medicineAnimal CellsMedicine and Health Scienceslcsh:ScienceProspective cohort studyTomographyMultidisciplinaryGlasgow Outcome ScaleRadiology and ImagingDrugsMiddle AgedBody FluidsIntraventricular hemorrhageTreatment OutcomeBloodNeurologyAnesthesiaFemaleAnatomyCellular TypesIntracranial HemorrhagesResearch ArticleHydrocephalusAdultPlateletsSubarachnoid hemorrhageConsciousnessImaging TechniquesCognitive NeuroscienceHemorrhageNeuroimagingSurgical and Invasive Medical ProceduresPatient AdvocacyResearch and Analysis Methods03 medical and health sciencesYoung AdultExtracorporeal Membrane OxygenationSigns and SymptomsMidline shiftDiagnostic MedicinemedicineExtracorporeal membrane oxygenationHumanscardiovascular diseasesRetrospective StudiesPharmacologyBlood Cellsbusiness.industryHeparinlcsh:RBiology and Life Sciences030208 emergency & critical care medicineRetrospective cohort studyCell Biologymedicine.diseaseHydrocephalusnervous system diseasesComputed Axial TomographyHealth CareCognitive Sciencelcsh:Qbusiness030217 neurology & neurosurgeryNeurosciencePloS one
researchProduct